Profile
STSS ISRG BDX ALC BDXA RMD
Company Name Sharps Technology, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. Becton, Dickinson and Company ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $305.44K $189.75B $48.46B $48.16B $47.95B $35.18B
Employees 0.06K 15.64K 70.00K 25.60K 0.00K 9.98K
CEO Mr. Robert M. Hayes Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott - Mr. Michael J. Farrell BE, MBA, SM
Ratings
STSS ISRG BDX ALC BDXA RMD
Quant Rating Score 2 3 3 3 5 4
Quant Rating Sell Neutral Neutral Neutral Strong Buy Buy
Trading
STSS ISRG BDX ALC BDXA RMD
Last Close $5.05 $538.16 $167.95 $95.88 $59.24 $243.09
High 52 $5.68 $610.45 $249.08 $100.76 $59.24 $257.65
Low 52 $0.01 $380.88 $165.15 $80.92 $59.24 $182.2
Price vs. 52 Week High -11.09 % -11.84 % -32.57 % -4.84 % 0 % -5.65 %
Price vs. 52 Week Low 50400 % 41.29 % 1.7 % 18.49 % 0 % 33.42 %
Total Return
STSS ISRG BDX ALC BDXA RMD
1 Month Return 35971.4 % 2.94 % -19.78 % 6.62 % 0 % 12.29 %
3 Month Return 1425.22 % -7.89 % -26.93 % 7.04 % 0 % 2.6 %
6 Month Return 79.72 % 0.32 % -27.5 % 3.53 % 0 % -3.68 %
9 Month Return 1820.15 % 16.13 % -28.8 % 3.19 % 0 % 12.24 %
YTD Return 145.15 % 3.1 % -25.97 % 12.95 % 0 % 6.3 %
1 Year Return 2069.24 % 39.62 % -28.53 % 17.7 % 0 % 12.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
STSS ISRG BDX ALC BDXA RMD
Dividend Yield Percentage (TTM) - - 2.36 % 0.27 % 2.37 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) -49.92 % 2.77 % 1.77 % 3.17 % 1.77 % 4.21 %
Dividend Per Share (TTM) - - 3.98 % 0.26 % 3.98 % 2.07 %
Payout Ratio (TTM) - - 76.77 % 12.35 % 76.77 % 23.14 %
Growth
STSS ISRG BDX ALC BDXA RMD
Asset Growth -37.96 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth 100 % 11.69 % 11.69 % 12.72 %
Revenue Growth - 4.16 % 4.16 % 10.95 %
Revenue 3 Year - -0.51 % -0.51 % 44.86 %
Revenue 5 Year - 8.72 % 8.72 % 74.97 %
Revenue 10 Year - 59.37 % 59.37 % 189.94 %
EBIT Growth -11.34 % 19.82 % 19.82 % 12.75 %
Net Income Growth 5.54 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share -1304.98 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share -3202.18 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share -3202.18 % -4.02 % -4.02 % 184.54 %
Operating Income Growth 4.94 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) 18.55 % 27.03 % 27.03 % 102.11 %
Operating 3 Year CFG -1507.39 % -18.43 % -18.43 % 87.99 %
Operating 5 Year CFG -3115.13 % 6.22 % 6.22 % 197.13 %
Operating 10 Year CFG -3115.13 % 45.24 % 45.24 % 244.62 %
EPS Growth -873.68 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth -873.68 % 18.62 % 18.62 % 13.63 %
Book Value Per Share 160.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share 364.73 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share 2498.39 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share 2498.39 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share - 74.3 % 74.3 % 91.97 %
Debt Growth - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth 23.22 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
STSS ISRG BDX ALC BDXA RMD
Gross Profit Margin TTM -4623.07 % 67.09 % 44.5 % 55.61 % 44.5 % 58.53 %
Return on Assets TTM -127.11 % 12.88 % 2.75 % 3.35 % 2.75 % 17.36 %
Return on Equity TTM -164.68 % 15.52 % 5.86 % 6.43 % 5.86 % 25.18 %
Return on Capital Employed TTM -452.36 % 13.9 % 5.05 % 5.03 % 5.05 % 24.33 %
Net Income Per EBT TTM 99.68 % 88.31 % 89.01 % 81.05 % 89.01 % 83.26 %
EBT Per Ebit TTM 96.88 % 114.09 % 71.19 % 88.89 % 71.19 % 97.84 %
EBIT Per Revenue TTM -117027.8 % 28.2 % 11.33 % 14.24 % 11.33 % 32.1 %
Cash Flow To Debt Ratio TTM -184.12 % - 17.12 % 40.08 % 17.12 % 196.83 %
Receivables Turnover TTM 0.08 7.13 6.89 4.77 6.89 5.53
Payables Turnover TTM 0.4 10.39 - 5.7 - 9.36
Inventory Turnover TTM 0.21 1.85 3.11 1.94 3.11 2.41
Fixed Asset Turnover TTM 0.2 % 181.6 % 313.98 % 205.17 % 313.98 % 729.93 %
Asset Turnover TTM 0.11 % 45.34 % 38.31 % 32.71 % 38.31 % 66.36 %
Operating Cash Flow Per Share TTM -1838.73 7.64 11.44 4.16 11.44 11.27
Free Cash Flow Per Share TTM -1875.56 4.88 8.98 3.1 8.98 10.66
Cash Per Share TTM 22927.06 % 1261.9 % 236.81 % 370.15 % 236.81 % 635.71 %
Operating Cash Flow Sales Ratio TTM -84239.53 % 31.34 % 15.81 % 20.74 % 15.81 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 102 % 63.9 % 78.51 % 74.53 % 78.51 % 94.64 %
Cash Flow Coverage Ratios TTM -184.12 % - 17.12 % 40.08 % 17.12 % 196.83 %
Price To Free Cash Flows Ratio TTM -0.04 108.72 18.71 31.39 18.59 22.49
Price To Operating Cash Flows Ratio TTM - 69.3 14.76 23.39 14.68 21.3
Price Cash Flow Ratio TTM - 69.3 14.76 23.39 14.68 21.3
Income Statement (TTM)
STSS ISRG BDX ALC BDXA RMD
Revenue $0B $8.35B $20.18B $9.91B $20.18B $4.69B
Gross Profit $0B $5.63B $9.13B $5.51B $9.13B $2.66B
Gross Profit Ratio 0% 67.46% 45.22% 55.61% 45.22% 56.67%
EBITDA $-0.01B $2.67B $4.82B $2.68B $4.82B $1.53B
Net Income $-0.01B $2.32B $1.71B $1.02B $1.71B $1.02B
EPS Diluted -2220 6.42 5.86 2.05 5.86 6.92
Balance Sheet (MRQ)
STSS ISRG BDX ALC BDXA RMD
Long Term Debt $0B $0B $17.94B $4.97B $17.94B $0.84B
Total Liabilities $0.01B $2.21B $31.4B $8.79B $31.4B $2.01B
Total Equity $0B $16.53B $25.89B $21.55B $25.89B $4.86B
Total Investments $0B $6.81B $0.45B $0.75B $0.45B $0.17B
Total Debt $0B $0B $20.11B $5.14B $20.11B $0.87B
Total Assets $0.01B $18.74B $57.29B $30.35B $57.29B $6.87B
Cash Flow Statement (TTM)
STSS ISRG BDX ALC BDXA RMD
Net Income $-0.01B $2.34B $1.71B $1.02B $1.71B $1.02B
Inventory $-0B $-0.83B $0.1B $-0.05B $0.1B $0.17B
Dividends Paid $0B $0B $-1.1B $-0.13B $-1.1B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.8B $2.08B $3.8B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.67B $-0.73B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.125
ALC Alcon Inc. 96.45
ANGO AngioDynamics, Inc. 9.115
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 153.97
ATRC AtriCure, Inc. 30.845
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 27.46
BAX Baxter International Inc. 31.34
BDX Becton, Dickinson and Company 170.08
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 11.35
BLFS BioLife Solutions, Inc. 24.36
COO The Cooper Companies, Inc. 83.15
DXR Daxor Corporation 7.4263
EKSO Ekso Bionics Holdings, Inc. 0.4248
FEMY Femasys Inc. 1.085
ETFs With Exposure to STSS
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 177.295
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
Unlock